Expand MLYS Menu
MLYS MENU

MLYS Latest Press Releases

-- March 24, 2026 --

Mineralys Therapeutics Appoints Jeffrey A. Munsie as Chief Legal Officer Globe Newswire 8:00 AM

-- March 16, 2026 --

Mineralys Therapeutics Reports Inducement Awards Under Nasdaq Listing Rule 5635(c)(4) Globe Newswire 4:05 PM

-- March 12, 2026 --

Mineralys Therapeutics Reports Fourth Quarter 2025 Financial Results and Provides Corporate Update Globe Newswire 4:05 PM

-- March 9, 2026 --

Mineralys Therapeutics Announces FDA Acceptance of NDA for Lorundrostat for Treatment of Adults with Hypertension and Topline Explore-OSA Trial Results Globe Newswire 4:30 PM
Mineralys Therapeutics to Announce Fourth Quarter and Full Year 2025 Financial Results and Host Conference Call on Thursday, March 12, 2026 Globe Newswire 8:00 AM

-- March 3, 2026 --

Chronic Kidney Disease Market Poised to Expand Significantly During Forecast Period (2025-2034) as Demand for Early Diagnosis and Novel Therapies Increases | DelveInsight PRNewswire 5:31 PM

-- February 26, 2026 --

Mineralys Therapeutics Reports Inducement Awards Under Nasdaq Listing Rule 5635(c)(4) Globe Newswire 4:05 PM

-- February 11, 2026 --

Mineralys Therapeutics Reports Inducement Awards Under Nasdaq Listing Rule 5635(c)(4) Globe Newswire 7:00 PM

-- January 6, 2026 --

Mineralys Therapeutics Provides Corporate Update and Announces Participation in Upcoming LifeSci Partners Corporate Access Event in January 2026 Globe Newswire 8:00 AM

-- December 12, 2025 --

Mineralys Therapeutics' Phase 3 Launch-HTN Trial of Lorundrostat Recognized in Inaugural Journal of the American Medical Association (JAMA) "Research of the Year" Roundup Globe Newswire 11:00 AM

-- November 26, 2025 --

Mineralys Therapeutics Reports Inducement Award Under Nasdaq Listing Rule 5635(c)(4) Globe Newswire 4:05 PM

-- November 10, 2025 --

Mineralys Therapeutics Reports Third Quarter 2025 Financial Results and Provides Corporate Update Globe Newswire 4:05 PM

-- November 7, 2025 --

Data for Lorundrostat in Chronic Kidney Disease and Hypertension Presented at American Society of Nephrology (ASN) Kidney Week 2025 Globe Newswire 6:10 PM

-- November 5, 2025 --

Mineralys Therapeutics to Participate in Upcoming Investor Conferences Globe Newswire 4:05 PM

-- November 3, 2025 --

Mineralys Therapeutics to Announce Third Quarter 2025 Financial Results and Host Conference Call on Monday, November 10, 2025 Globe Newswire 8:00 AM
Market Data Delayed 15 Minutes